TANDEM

WIPO WIPO 2012

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark TANDEM was filed as Figurative mark on 12/07/2012 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Signs, notations, symbols #Letters presenting a special form of writing #Dots #Letters in heavy characters #Letters overlapping

Trademark Details Last update: December 12, 2022

Trademark form Figurative mark
File reference 1157254
Countries Australia Switzerland Colombia Cuba em Japan
Base trademark US No. 85647086, June 8, 2012
Application date December 7, 2012
Expiration date December 7, 2032

Trademark owner

3100 Hansen Way
Palo Alto CA 94304
US

Trademark representatives

One Embarcadero Center, Suite 2200 San Francisco CA 94111 US

goods and services

10 Medical devices; medical devices for embolization, namely, syringes and vials filled with embolic microspheres for embolization; medical devices for embolization, namely, embolic microspheres for embolization in the form of particles; medical devices for embolization, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; medical devices for embolization, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; medical devices for embolization, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; medical devices for embolization, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; medical devices for embolization, namely, embolic microspheres in the form of particles to treat vascular conditions; medical microspheres for transarterial embolization of tumors, chemoembolization, transarterial chemoembolization, lesion devascularization, lobe devascularization, and proximal embolization; medical microspheres for the treatment of hypervascular tumors and arteriovenous malformations; medical microspheres for super selective, targeted chemoembolization of a hypervascular tissue or tumor; drug delivery devices, namely drug delivery microspheres for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment; drug delivery devices, namely drug delivery beads for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment

Trademark history

Date Document number Area Entry
December 7, 2022 2022/49 Gaz Extension
January 8, 2015 2015/2 Gaz JP Rejection
March 17, 2014 2014/12 Gaz CU Rejection
March 4, 2014 2014/10 Gaz EM Rejection
March 3, 2014 2014/19 Gaz RAW: Limitation
February 6, 2014 2014/6 Gaz JP Rejection
January 27, 2014 2014/9 Gaz CN Rejection
December 31, 2013 2014/2 Gaz CO Rejection
June 3, 2013 2013/25 Gaz US Correction
May 6, 2013 2013/19 Gaz AU Rejection
December 7, 2012 2013/16 Gaz US Registration
Partial deletion

ID: 141157254